Generation and characterization of telomerase transfected human lymphatic endothelial cells with an extended life span

被引:87
作者
Nisato, RE
Harrison, JA
Buser, R
Orci, L
Rinsch, C
Montesano, R
Dupraz, P
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[2] Isotis SA, Lausanne, Switzerland
关键词
D O I
10.1016/S0002-9440(10)63271-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The study of lymphatic endothelial cells and lymphangiogenesis has, in the past, been hampered by the lack of lymphatic endothelial-specific markers. The recent discovery of several such markers has permitted the isolation of lymphatic endothelial cells (LECs) from human skin. However, cell numbers are limited and purity is variable with the different isolation procedures. To overcome these problems, we have transfected human dermal microvascular endothelial cells (HDMVECs) with a retrovirus containing the coding region of human telomerase reverse transcriptase (hTERT), and have produced a cell line, hTERT-HDLEC, with an extended lifespan. hTERTHDLEC exhibit a typical cobblestone morphology when grown in culture, are contact-inhibited, and express endothelial cell-specific markers. hTERTHDLEC also express the recognized lymphatic markers, Prox-1, LYVE-1 and podoplanin, as well as integrin alpha9, but do not express CD34. They also form tube-like structures in three-dimensional collagen gels when stimulated with vascular endothelial growth factors -A and -C. Based on these currently recognized criteria, these cells are LEC. Surprisingly, we also found that the widely studied HMEC-1 cell line expresses recognized lymphatic markers; however, these cells are also CD34-positive. In summary, the ectopic expression of hTERT increases the life span of LECs and does not affect their capacity to form tubelike structures in a collagen matrix. The production and characterization of hTERT-HDLEC will facilitate the study of the properties of lymphatic endothelium invitro.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 50 条
[41]   Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor [J].
Petrova, TV ;
Mäkinen, T ;
Mäkelä, TP ;
Saarela, J ;
Virtanen, I ;
Ferrell, RE ;
Finegold, DN ;
Kerjaschki, D ;
Ylä-Herttuala, S ;
Alitalo, K .
EMBO JOURNAL, 2002, 21 (17) :4593-4599
[42]   Molecular characterization of lymphatic endothelial cells [J].
Podgrabinska, S ;
Braun, P ;
Velasco, P ;
Kloos, B ;
Pepper, MS ;
Jackson, DG ;
Skobe, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16069-16074
[43]   A ROLE FOR BOTH RB AND P53 IN THE REGULATION OF HUMAN CELLULAR SENESCENCE [J].
SHAY, JW ;
PEREIRASMITH, OM ;
WRIGHT, WE .
EXPERIMENTAL CELL RESEARCH, 1991, 196 (01) :33-39
[44]   Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells [J].
Taraboletti, G ;
Sonzogni, L ;
Vergani, V ;
Hosseini, G ;
Ceruti, R ;
Ghilardi, C ;
Bastone, A ;
Toschi, E ;
Borsotti, P ;
Scanziani, E ;
Giavazzi, R ;
Pepper, MS ;
Stetler-Stevenson, WG ;
Bani, MR .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (02) :384-394
[45]  
VEIKKOLA T, 2003, EMBO J, V17, P2006
[46]   Prox1 function is required for the development of the murine lymphatic system [J].
Wigle, JT ;
Oliver, G .
CELL, 1999, 98 (06) :769-778
[47]   CHARACTERIZATION OF EXPRESSION AND MODULATION OF CELL-ADHESION MOLECULES ON AN IMMORTALIZED HUMAN DERMAL MICROVASCULAR ENDOTHELIAL-CELL LINE (HMEC-1) [J].
XU, YL ;
SWERLICK, RA ;
SEPP, N ;
BOSSE, D ;
ADES, EW ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :833-837
[48]   Human endothelial cell life extension by telomerase expression [J].
Yang, JW ;
Chang, E ;
Cherry, AM ;
Bangs, CD ;
Oei, Y ;
Bodnar, A ;
Bronstein, A ;
Chiu, CP ;
Herron, GS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26141-26148
[49]   Telomerized human microvasculature is functional in vivo [J].
Yang, JW ;
Nagavarapu, U ;
Relloma, K ;
Sjaastad, MD ;
Moss, WC ;
Passaniti, A ;
Herron, GS .
NATURE BIOTECHNOLOGY, 2001, 19 (03) :219-224
[50]  
Zhu ZP, 1998, CANCER RES, V58, P3209